Suchergebnisse - "Chilton, Robert J"

PubPharm (18)

1

Mineralocorticoid receptor antagonists in cardiovascular translational biology

enthalten in: Cardiovascular endocrinology & metabolism | 2023

von Chilton, R. | Silva-Cardoso, J.

2

SGLT2 inhibitors : a narrative review of efficacy and safety

enthalten in: Journal of osteopathic medicine | 2021

von Nelinson, D. | Sosa, J. | Chilton, R.

3

Cardiovascular risk and the implications for clinical practice of cardiovascular outcome trials in type 2 diabetes

enthalten in: Primary care diabetes | 2020

von Chilton, R. | Dungan, K. | Shubrook, J. | +1

4

Cardiorenal protection with SGLT2 : Lessons from the cardiovascular outcome trials

enthalten in: Journal of diabetes | 2020

von Silva-Cardoso, J. | Sheikh, O. | Nashawi, M. | +4

5

Effects of sodium-glucose cotransporter-2 inhibitors on the cardiovascular and renal complications of type 2 diabetes

enthalten in: Diabetes, obesity & metabolism | 2020

von Chilton, R.

6

The Evolving Role of the Cardiologist in the Management of Type 2 Diabetes

enthalten in: Current diabetes reports | 2018

von Chilton, R. | Gallegos, K. | Silva-Cardoso, J. | +2

7

EMPA-REG OUTCOME : The Cardiologist's Point of View

enthalten in: The American journal of cardiology | 2017

von Pham, S. | Chilton, R.

8

Applications of miRNA technology for atherosclerosis

enthalten in: Current atherosclerosis reports | 2014

von Toba, H. | Cortez, D. | Lindsey, M. | +1

9

Left ventricular remodeling : one small step for the extracellular matrix will translate to a giant leap for the myocardium

enthalten in: Congestive heart failure (Greenwich, Conn.) | 2013

von Yabluchanskiy, A. | Chilton, R. | Lindsey, M.

10

Matrix metalloproteinases : drug targets for myocardial infarction

enthalten in: Current drug targets | 2013

von Yabluchanskiy, A. | Li, Y. | Chilton, R. | +1